SCHEMBL27101307

SCHEMBL27101307

COC(=O)C(=O)/C=C(\O)c1ccc(C)c(O)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.65
ALDH1A1 P00352 2/20 0.65
MAPT P10636 1/20 0.65
CA12 O43570 4/20 0.40
CA1 P00915 4/20 0.40
CA2 P00918 4/20 0.40
CA9 Q16790 4/20 0.40
XDH P47989 2/20 0.40
CA7 P43166 2/20 0.40
CA14 Q9ULX7 2/20 0.40
GAA P10253 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP1A2 P05177 1/20 0.36
HSD17B1 P14061 1/20 0.35
CLK1 P49759 1/20 0.35
DYRK1A Q13627 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8367195 0.88 MAPT (0.69) KDM4EALDH1A1MAPTCA12CA1
SCHEMBL8367198 0.88 MAPT (0.69) KDM4EALDH1A1MAPTCA12CA1
SCHEMBL17731959 0.84 MAPT (0.59) KDM4EALDH1A1MAPTCA12CA1
SCHEMBL17731956 0.84 MAPT (0.59) KDM4EALDH1A1MAPTCA12CA1
SCHEMBL17732027 0.84 KDM4E (0.59) KDM4EALDH1A1MAPTCA12CA1
SCHEMBL17732029 0.84 KDM4E (0.59) KDM4EALDH1A1MAPTCA12CA1
SCHEMBL17731955 0.84 MAPT (0.59) KDM4EALDH1A1MAPTCA12CA1
SCHEMBL8369833 0.81 ALDH1A1 (0.63) KDM4EALDH1A1MAPTCA12CA1
SCHEMBL8369834 0.81 ALDH1A1 (0.63) KDM4EALDH1A1MAPTCA12CA1
SCHEMBL8368078 0.79 ALDH1A1 (1.00) KDM4EALDH1A1MAPTCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067600-A1 SMALL MOLECULE INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (mtPTP) UNIVERSITY OF KANSAS (US) 2024-02-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067600-A1 SMALL MOLECULE INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (mtPTP) MTCH2, TIMM50, TIMM10 KDM4E 4630/4885ALDH1A1 3811/4885MAPT 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.